ADMA Biologics
Stock Forecast, Prediction & Price Target
ADMA Biologics Financial Estimates
ADMA Biologics Revenue Estimates
ADMA Biologics EBITDA Estimates
ADMA Biologics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $80.94M N/A | $154.07M 90.35% | $258.21M 67.58% | Avg: $414.47M Low: $377.65M High: $451.29M avg. 60.51% | Avg: $471.63M Low: $457.67M High: $486.37M avg. 13.78% | Avg: $518.7M Low: $503.35M High: $534.91M avg. 9.97% | Avg: $543.95M Low: $527.85M High: $560.95M avg. 4.86% |
Net Income
% change YoY
| $-84.45M N/A | $-85.18M -0.86% | $-28.23M 66.84% | Avg: $127.46M Low: $103.02M High: $132.14M avg. 551.38% | Avg: $143.86M Low: $118.70M High: $145.58M avg. 12.86% | Avg: $153.05M Low: $147.16M High: $159.27M avg. 6.38% | Avg: $159.02M Low: $152.90M High: $165.48M avg. 3.90% |
EBITDA
% change YoY
| $-57.87M N/A | $-39.23M 32.20% | $5.12M 113.04% | Avg: $-236.55M Low: $-257.56M High: $-215.53M avg. -4720.21% | Avg: $-269.17M Low: $-277.59M High: $-261.20M avg. -13.78% | Avg: $-296.03M Low: $-305.29M High: $-287.27M avg. -9.97% | Avg: $-310.44M Low: $-320.15M High: $-301.26M avg. -4.86% |
EPS
% change YoY
| -$0.61 N/A | -$0.43 29.50% | -$0.13 69.76% | Avg: $0.54 Low: $0.46 High: $0.59 avg. 515.38% | Avg: $0.6 Low: $0.53 High: $0.65 avg. 11.72% | Avg: $0.68 Low: $0.66 High: $0.71 avg. 13.25% | Avg: $0.71 Low: $0.68 High: $0.74 avg. 3.90% |
Operating Expenses
% change YoY
| $59.54M N/A | $74.63M 25.32% | $66.58M -10.77% | Avg: $234.47M Low: $213.64M High: $255.30M avg. 252.13% | Avg: $266.80M Low: $258.91M High: $275.15M avg. 13.78% | Avg: $293.43M Low: $284.75M High: $302.60M avg. 9.97% | Avg: $307.71M Low: $298.61M High: $317.34M avg. 4.86% |
FAQ
What is ADMA Biologics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 143.63% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is 103.02M, average is 127.46M and high is 132.14M.
What is ADMA Biologics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.28% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $377.65M, average is $414.47M and high is $451.29M.
What is ADMA Biologics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 136.06% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is $0.46, average is $0.54 and high is $0.59.
What is the best performing analyst?
In the last twelve months analysts have been covering ADMA Biologics stock. The most successful analyst is Raghuram Selvaraju.